Westwood Insurance Agency Expands Builder Relationships Through New Collaboration with Legend Homes — Neutral
BWIN Business Wire — July 24, 2025WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Westwood Insurance Agency LLC (“Westwood”), the preeminent insurance agency for the homebuilding industry, announced today a new collaboration with Legend Homes, a Texas-based builder ranked as a top 40 home builder in the United States1. Through its relationship with Westwood, Legend Homes will be able to embed an offer of home insurance early in its customers' homebuying journey. Within 24 hours after homebuyers sign a contract to purchase a new home,.
Roper Technologies: Strong Fundamentals And Attractive Valuation Make It A Buy — Positive
ROP Seeking Alpha — July 24, 2025Strong software bookings, M&A, and AI to drive solid revenue growth. Recurring software mix and AI gain support margin expansion. Valuation below the historical average offers room for multiple re-rating.
Nucor to Report Q2 Earnings: What's in the Offing for the Stock? — Positive
NUE Zacks Investment Research — July 24, 2025NUE is expected to post strong Q2 as tariff-fueled steel price spikes and higher volumes are likely to lift performance.
West Bancorp (WTBA) Beats Q2 Earnings and Revenue Estimates — Positive
WTBA Zacks Investment Research — July 24, 2025West Bancorp (WTBA) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.31 per share a year ago.
Tickets on Sale for Simmons Bank Championship presented by Stephens — Neutral
SFNC PRNewsWire — July 24, 2025LITTLE ROCK, Ark. , July 24, 2025 /PRNewswire/ -- Tickets for the Simmons Bank Championship presented by Stephens—a PGA TOUR Champions playoff event—are now on sale to the public.
IDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma — Neutral
IDYA PRNewsWire — July 24, 2025The presentation will include data from over 90 patients in both the plaque brachytherapy and enucleation-eligible cohorts Darovasertib has received U.S. FDA Breakthrough Therapy Designation for use in neoadjuvant uveal melanoma for subjects requiring enucleation Initiated a multi-site, global randomized Phase 3 neoadjuvant registrational trial in primary uveal melanoma (OptimUM-10) in Q3 2025 SOUTH SAN FRANCISCO, Calif. , July 24, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced that results from a multi-site global Phase 2 study of neoadjuvant darovasertib in primary uveal melanoma was accepted for a Proffered Paper oral presentation …
JUNO BEACH, Fla. , July 24, 2025 /PRNewswire/ -- The board of directors of NextEra Energy, Inc. (NYSE: NEE) declared a regular quarterly common stock dividend of $0.5665 per share.
Walrus and Veea Inc. Announce Strategic Partnership to Unlock High-Performance Edge Utility for Decentralized Data Storage — Neutral
VEEA GlobeNewsWire — July 24, 2025PALO ALTO, Calif. and NEW YORK, July 24, 2025 (GLOBE NEWSWIRE) -- Walrus, the decentralized data storage protocol built by Mysten Labs, the original contributors to Sui, and Veea Inc. (Nasdaq:VEEA), a leader in intelligent edge infrastructure, today announced the adoption of Walrus as a VeeaHub STAX™ edge solution to provide high-performance data transport and storage capabilities for the decentralized network.
Energy Vault Closes $18 Million Project Financing for 57 MW/114 MWh Cross Trails BESS Serving the Texas ERCOT Market — Neutral
NRGV Business Wire — July 24, 2025WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)---- $NRGV--Energy Vault Holdings Inc. (NYSE: NRGV) (“Energy Vault” or the “Company”), a leader in sustainable, grid-scale energy storage solutions, today announced the successful close of $18 million in project financing for its Cross Trails battery energy storage system (BESS). The financing marks another milestone in the Company's execution of its ‘Own & Operate' growth and asset management strategy, originally outlined during the May 2024 Investor and Anal.
Stock Market Live July 24: Tech Earnings May Keep S&P 500 (VOO) Above Water on Thursday — Negative
VOO 24/7 Wall Street — July 24, 2025The S&P 500 enters Thursday trading right where it left off Wednesday night — neither up nor down.
Novo Nordisk: Undervalued Despite Strong Growth Trend & Solid Market Share — Positive
NVO Seeking Alpha — July 24, 2025I am bullish on Novo Nordisk due to its 62% global GLP-1 market share and dominant Ozempic sales, supporting long-term leadership. Novo Nordisk's diversified GLP-1 portfolio, including Rybelsus and pending pill versions, positions it well against competitors and broadens its addressable market. Consistent double-digit revenue and profit growth, plus strong Q2 2025 expectations, reflect robust demand and effective cost management.
After a rough start to the year, tech stocks are back on top. As of this writing, the tech-heavy Nasdaq Composite is up 28% over the last three months.
AlikeAudience Launches AURAR: Revolutionary Data Collaboration Tool Now Available in Snowflake Marketplace — Neutral
SNOW Business Wire — July 24, 2025SAN FRANCISCO--(BUSINESS WIRE)--AlikeAudience, a leading data science company specializing in omnichannel data activation, today announced the launch of AURAR, a groundbreaking data collaboration tool, with a native Lookalike model application now available in the Snowflake Marketplace. With AURAR, AlikeAudience is empowering marketers to prepare ideal audiences through seamless, secure, and accelerated collaboration with first-party data. The launch of AURAR addresses the fundamental shifts dr.
Candel Therapeutics receives EMA Orphan Designation for immunotherapy candidate CAN-2409 — Positive
CADL Proactive Investors — July 24, 2025Candel Therapeutics Inc (NASDAQ:CADL) announced that the European Medicines Agency (EMA) has granted Orphan Designation to its investigational immunotherapy CAN-2409 for the treatment of pancreatic cancer. The designation adds to CAN-2409's existing Orphan Drug Designation and Fast Track Designation from the US Food and Drug Administration for pancreatic ductal adenocarcinoma.
UnitedHealth Group Inc. (NYSE: UNH) shares tumbled another 4% in premarket trading following the company's disclosure of a Department of Justice investigation into its Medicare program practices, adding to what has already been a disastrous year for the healthcare giant.
Here's our initial take on Novocure's (NVCR -9.99%) fiscal 2025 second-quarter financial report.
Stocks rise to more records after U.S. strikes trade deal with Japan — Positive
EWJ Fast Company — July 24, 2025U.S. stocks are rising toward more records on Wednesday following a trade deal between the world's No. 1 and No. 4 economies, one that would lower proposed tariffs on Japanese imports coming to the United States.
RJF Falls as Q3 Earnings Lag on Legal Reserve, IB & Trading Stay Solid — Neutral
RJF Zacks Investment Research — July 24, 2025Raymond James misses fiscal Q3 earnings expectations due to a $58M legal reserve. On the other hand, trading and IB strength help lift revenues.
Best Income Stocks to Buy for July 24th — Positive
BHB CRGY HII Zacks Investment Research — July 24, 2025CRGY, BHB and HII made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 24, 2025.